awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26771601-BBA446FB-4C31-49CF-9BEC-BFAB30FEC53E
Q26771601-BBA446FB-4C31-49CF-9BEC-BFAB30FEC53E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771601-BBA446FB-4C31-49CF-9BEC-BFAB30FEC53E
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
P2860
Q26771601-BBA446FB-4C31-49CF-9BEC-BFAB30FEC53E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771601-BBA446FB-4C31-49CF-9BEC-BFAB30FEC53E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a7b141c6195dbd6d2c5023630647b131eb34fde
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.